课题基金 / 基金详情

Role of endogenous nitric oxide synthase inhibitors in penile erection and their potential use in the treatment of erectile dysfunction.

Role of endogenous nitric oxide synthase inhibitors in penile erection and their potential use in the treatment of erectile dysfunction.
内源性一氧化氮合酶抑制剂在阴茎勃起中的作用及其在治疗勃起功能障碍中的潜在用途。
批准号:
11671538
负责人:
TSUJII Toshihiko
金额:
$1.66万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

TSUJII Toshihiko的其他基金

相似基金

相关文献

中文摘要
翻译
为了探讨缺血和高血糖对阴茎勃起的影响,我们用双侧髂动脉部分阻断致阴茎缺血和四氧嘧啶致高血糖的家兔阴茎海绵体进行药理学实验,缺血:1)神经源性和NO介导的舒张功能受损,L精氨酸可使其恢复;(2)EPS引起的cGMP生成减少;(3)L-NMA和ADMA含量增加,但SDMA含量不增加;这些结果表明,缺血时神经源性和NO介导的阴茎舒张功能受损与L-NMA和ADMA积累增加和NOS活性降低密切相关,这将导致NO产生/释放加速减少。1)SNP诱导的舒张或神经源性和NO介导的舒张均无显著变化,2)减少由卡巴胆碱或硝普钠刺激的环GMP产生。3)NOS活性和鸟苷酸环化酶活性无明显变化; 4)内源性NOS抑制剂L-NMA和ADMA含量降低,而SDMA含量无明显变化。Hyerplatin似乎在几个不同的水平上影响阴茎海绵体中的NO-cGMP途径。缩写:NOS,一氧化氮合酶; L-NMA,N^G甲基-L-精氨酸; ADMA,不对称N^G,N^G-二甲基L-精氨酸; SDMA,对称N^G,N '^G-二甲基L-精氨酸; SNP,硝普钠; EFS,电场刺激
英文摘要
In order to examine the effect of ischemia and hyperglycemia on the penile erection, we did pharmacological experiments using corpus cavernosum from 1) rabbits with penile ischemia by partial occlusion of bilateral iliac arteries and 2) rabbits with alloxane-induced hyperglycemia.Ischemia : 1) impaired neurogenic and NO-mediated relaxation that was restored by L arginine; no changes in SNP-induced relaxation, 2) impaired cyclic GMP production induced by EPS, 3) increased tissue contents of L-NMA and ADMA, but not SDMA, 4) reduced NOS activity that was restored by L-arginine. These results suggest that the impaired neurogenic and NO-mediated penile relaxation with ischemia is closely related to the increased accumulation of L-NMA and ADMA and decreased NOS activity, which would result in an accelerated reduction in NO production/release.Hyoerglycemia : 1) no significant changes in either SNP-induced relaxation or neurogenic and NO-mediated relaxation, 2) reduced cyclic GMP production stimulated by carbachol or sodium niroprusside. 3) no changes in NOS activity and guanylate cyclase, 4) reduced tissue contents of the endogenous NOS inhibitors, L-NMA and ADMA, but not SDMA. Hyerglycemia seems to affect the NO-cGMP pathway in corpus cavernosum at several different levels.Abbreviations : NOS, nitric oxide synthase ; L-NMA, N^G methyl-L-arginine ; ADMA, asymmetric N^G, N^G-dimethyl L-arginine ; SDMA, symmetric N^G,N'^G-dimethyl L-arginine ; SNP, sodium nitroprusside ; EFS, electrical field stimulation
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Ichiyanagi N, Tsu.jii T, Masuda K.Goto M.Azuma H: "Changed responsiveness of the detrusor in rabbits with ailoxan-induced hyperglycemia : possible role of 5-hydroxytriptamine for diabetic bladder dysfunction"J Urol.. (in press). (2002)
Ichiyanagi N、Tsu.jii T、Masuda K.Goto M.Azuma H:“Aloxan 引起的高血糖兔子逼尿肌的反应性改变:5-羟基三胺对糖尿病膀胱功能障碍的可能作用”J Urol..(出版中)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tsujii T, Masuda H, Ichiyanagi N, Goto M Azuma H: "Impaired cGMP production in corpus cavernosum of hyperglycemic rabbits and its reversal by aldose reductase inhibitor"Jpn.J.Pharmacol.. 85(Sppl). 214 (2001)
Tsujii T、Masuda H、Ichiyanagi N、Goto M Azuma H:“高血糖兔海绵体内 cGMP 产生受损及其通过醛糖还原酶抑制剂的逆转”Jpn.J.Pharmacol.. 85(Sppl)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Masuda H, Tsujii T, Azuma H, Oshima H.: "Role of a central muscarinic cholinergic pathway for relaxation of the proximal urethra during voiding phase in the rats"J Urol.. 165. 999-1003 (2001)
Masuda H、Tsujii T、Azuma H、Oshima H.:“中枢毒蕈碱胆碱能通路对大鼠排尿期近端尿道松弛的作用”J Urol.. 165. 999-1003 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Masuda H, Tsujii T, Okuno T, Kihara K, Goto M and Azuma H: "Involvement of accumulated endogenous NOS inhibitors and decreased NOS activity in the impaired neurogenic relaxation of the rabbit proximal urethra with Ischemia"Br. J. Pharmacol.. 133. 97-106 (
Masuda H、Tsujii T、Okuno T、Kihara K、Goto M 和 Azuma H:“内源性 NOS 抑制剂积累和 NOS 活性降低导致兔近端尿道缺血神经源性松弛受损”Br。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 6 条
    Study of the role of pituitary adenylate cyclase activating polypeptide (PACAP) as a neurotransmitter in the urogenital organs.
    海外基金